Rezolute reports first quarter fiscal 2024 results

Redwood city, calif., nov. 13, 2023 (globe newswire) -- rezolute, inc. (nasdaq: rzlt), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced its financial results for the first quarter of fiscal 2024 ended september 30, 2023.

RZLT Ratings Summary

RZLT Quant Ranking